British pharmaceutical company Reckitt Benckiser Group PLC was hit with a stock drop suit Monday in New Jersey federal court, shortly after announcing it will pay U.S. authorities up to $1.4 billion to settle an investigation into an opioid addiction medication…

Read this piece in its entirety at Law360.